TY - JOUR
T1 - Genomic risk factors in sudden infant death syndrome
AU - Van Norstrand, David W.
AU - Ackerman, Michael J.
N1 - Funding Information:
We gratefully acknowledge David Tester and Dr Argelia Medeiros-Domingo for their critical review of the manuscript. This work was supported by the National Institutes of Health (HD42569) and the Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death program.
PY - 2010
Y1 - 2010
N2 - Sudden infant death syndrome (SIDS) is a major contributor to postneonatal infant death, and is the third leading cause of infant mortality in the USA. While public health efforts have reduced these deaths in recent years, the pathogenesis of SIDS remains unclear. Epidemiological data on SIDS-related deaths have suggested genetic factors, and many studies have attempted to identify SIDS-associated genes. This has resulted in a large body of literature implicating various genes and their encoded proteins and signaling pathways in numerous cohorts of various sizes and ethnicities. This review has undertaken a systematic evaluation of these studies, identifying the pathways that have been implicated in these studies, including central nervous system pathways, cardiac channelopathies, immune dysfunction, metabolism/ energy pathways, and nicotine response. This review also explores how new genomic techniques will aid in advancing our knowledge of the genomic risk factors associated with SIDS, including SNPs and copy number variation. Last, this review explores how the current information can be applied to aid in our assessment of the at risk infant population.
AB - Sudden infant death syndrome (SIDS) is a major contributor to postneonatal infant death, and is the third leading cause of infant mortality in the USA. While public health efforts have reduced these deaths in recent years, the pathogenesis of SIDS remains unclear. Epidemiological data on SIDS-related deaths have suggested genetic factors, and many studies have attempted to identify SIDS-associated genes. This has resulted in a large body of literature implicating various genes and their encoded proteins and signaling pathways in numerous cohorts of various sizes and ethnicities. This review has undertaken a systematic evaluation of these studies, identifying the pathways that have been implicated in these studies, including central nervous system pathways, cardiac channelopathies, immune dysfunction, metabolism/ energy pathways, and nicotine response. This review also explores how new genomic techniques will aid in advancing our knowledge of the genomic risk factors associated with SIDS, including SNPs and copy number variation. Last, this review explores how the current information can be applied to aid in our assessment of the at risk infant population.
UR - http://www.scopus.com/inward/record.url?scp=78751684508&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78751684508&partnerID=8YFLogxK
U2 - 10.1186/gm207
DO - 10.1186/gm207
M3 - Review article
C2 - 21122164
AN - SCOPUS:78751684508
SN - 1756-994X
VL - 2
JO - Genome medicine
JF - Genome medicine
IS - 11
M1 - 86
ER -